Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05936294 · ClinicalTrials.gov registry record · NA
Adaptive Cardiac Resynchronization Therapy in Patients With RBBB
A NA study, sponsored by Henry Ford Health System.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05936294: Clinical Trial NA study, sponsored by Henry Ford Health System.
NCT05936294 is a NA study that was terminated before completion, run by Henry Ford Health System. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05936294, a NA study, was terminated before completion, sponsored by Henry Ford Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will address whether acute adaptive RV pacing in sinus rhythm patients with severe LV systolic dysfunction and RBBB is superior to no ventricular pacing, and is as effective as echocardiographically optimized biventricular (BIV) pacing based on Medtronic ECG belt and cardiac performance as assessed by the echocardiographic parameters of RV and LV function.
Primary Outcome
Echocardiographic parameters to measure cardiac function, including: 1. Left Ventricular Outflow Tract velocity time interval(LVOT VTI), 2. dP/dt of Left Ventricle (LV) and RV, 3. Myocardial Performance Index (MPI), 4. Right Ventricular Outflow Tractvelocity time interval (RVOT VTI); and 5. 3D derived Systolic Dyssynchrony Index (SDI).
Interventions
- DIAGNOSTIC_TEST Optimization of CRT Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Why NCT05936294 stopped before completion
NCT05936294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Optimization of CRT Device is the first listed.
NCT05936294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05936294 about?
NCT05936294 is a clinical study titled "Adaptive Cardiac Resynchronization Therapy in Patients With RBBB". This study will address whether acute adaptive RV pacing in sinus rhythm patients with severe LV systolic dysfunction and RBBB is superior to no ventricular pacing, and is as effective as echocardiographically optimized biventricular (BIV) pacing based on Medtronic ECG belt and cardiac performance a...
What is the current status of trial NCT05936294?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-09-15. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT05936294?
The interventions under investigation include: Optimization of CRT Device (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05936294?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05936294's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI